Internal Medicine · Council Bluffs, IA
NPI
1366458945
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1701 West Broadway
Council Bluffs, IA, 51501
Phone (712) 256-5600
Groups this clinician bills Medicare through
Medicare paid, 2024
$56K
1,430 services
Medicare patients, 2024
107
Average age 73
Drug cost, 2024
$1.6M
8,337 prescriptions
Company payments, 2025
$4,696
From 42 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Diana J Rabadi-Marar was code 36415 (venipuncture blood collection), 304 times for 101 patients. In total Diana J Rabadi-Marar billed 1,430 services in 51 codes, and Medicare paid $56K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-03-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 304 | 101 | $8.47 | $2,574 |
| 99214 Office E&M - Established | Office | 247 | 93 | $77.02 | $19K |
| 81003 Clinical Chemistry | Office | 120 | 78 | $2.20 | $264 |
| 82043 Clinical Chemistry | Office | 84 | 71 | $5.62 | $472 |
| 82570 Clinical Chemistry | Office | 84 | 71 | $5.04 | $424 |
| 99213 Office E&M - Established | Office | 59 | 36 | $51.28 | $3,026 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 49 | 49 | $119.69 | $5,865 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 47 | 47 | $17.30 | $813 |
| 77080 Standard X-ray | Office | 43 | 43 | $34.99 | $1,505 |
| G0008 Administration of influenza virus vaccine | Office | 42 | 41 | $29.94 | $1,257 |
| 90656 Vaccine Product | Office | 41 | 41 | $21.90 | $898 |
| 90677 Vaccine Product | Office | 35 | 35 | $287.79 | $10K |
| 93000 Electrocardiogram | Office | 34 | 28 | $9.15 | $311 |
| G0009 Administration of pneumococcal vaccine | Office | 34 | 34 | $29.94 | $1,018 |
| 99215 Office E&M - Established | Office | 25 | 20 | $125.99 | $3,150 |
By year: 2022 $48K for 1,920 services; 2023 $53K for 1,394 services; 2024 $56K for 1,430 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 304 | 101 | $8.47 | $2,574 |
| 81003 Clinical Chemistry | 120 | 78 | $2.20 | $264 |
| 82043 Clinical Chemistry | 84 | 71 | $5.62 | $472 |
| 82570 Clinical Chemistry | 84 | 71 | $5.04 | $424 |
Medicare prescription drug claims, 2024
In 2024, the drug Diana J Rabadi-Marar prescribed most often to Medicare patients was Atorvastatin Calcium, with 328 prescriptions and refills. In total Diana J Rabadi-Marar wrote 8,337 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 328 | 717 | 75 | $2,724 |
| Levothyroxine Sodium Generic | 308 | 746 | 73 | $1,766 |
| Carvedilol Generic | 301 | 631 | 65 | $1,747 |
| Omeprazole Generic | 258 | 590 | 63 | $5,452 |
| Losartan Potassium Generic | 229 | 606 | 61 | $1,375 |
| Rosuvastatin Calcium Generic | 216 | 601 | 57 | $1,804 |
| Lisinopril Generic | 212 | 494 | 51 | $1,141 |
| Farxiga Dapagliflozin Propanediol | 197 | 327 | 43 | $184K |
| Amlodipine Besylate Generic | 180 | 473 | 46 | $928 |
| Gabapentin Generic | 168 | 259 | 35 | $2,500 |
| Mounjaro Tirzepatide | 167 | 199 | 24 | $216K |
| Pantoprazole Sodium Generic | 161 | 355 | 39 | $1,539 |
| Duloxetine Hcl Generic | 158 | 297 | 31 | $3,465 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 153 | 197 | 40 | $128K |
| Kerendia Finerenone | 148 | 186 | 27 | $110K |
Brand drugs: 2,027 claims; generic drugs: 6,253 claims; opioid claims: 158.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Diana J Rabadi-Marar $4,696 ($4,696 in general payments such as food, travel and fees) from 42 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $1,402.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $1,402 |
| Novo Nordisk Inc NVO | 19 | $438 |
| Abbvie Inc. ABBV | 19 | $304 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $278 |
| Amgen Inc. AMGN | 14 | $267 |
| Lilly USA, LLC LLY | 11 | $217 |
| Astellas Pharma US Inc 4503.T | 6 | $195 |
| GlaxoSmithKline, LLC. GSK | 13 | $180 |
| Sumitomo Pharma America, Inc. 4506.T | 8 | $162 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $124 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.